nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—CYP1A2—Estropipate—osteoporosis	0.199	0.53	CbGbCtD
Phenylephrine—CYP1A2—Conjugated Estrogens—osteoporosis	0.094	0.251	CbGbCtD
Phenylephrine—CYP1A2—Estradiol—osteoporosis	0.0826	0.22	CbGbCtD
Phenylephrine—Immune system disorder—Risedronate—osteoporosis	0.00202	0.00323	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00201	0.00322	CcSEcCtD
Phenylephrine—Mediastinal disorder—Risedronate—osteoporosis	0.00201	0.00322	CcSEcCtD
Phenylephrine—Chest pain—Ibandronate—osteoporosis	0.00201	0.00321	CcSEcCtD
Phenylephrine—Mental disorder—Ethinyl Estradiol—osteoporosis	0.002	0.00321	CcSEcCtD
Phenylephrine—Arrhythmia—Risedronate—osteoporosis	0.00199	0.00319	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00199	0.00319	CcSEcCtD
Phenylephrine—Hypertension—Calcitriol—osteoporosis	0.00199	0.00319	CcSEcCtD
Phenylephrine—Bradycardia—Zoledronate—osteoporosis	0.00197	0.00316	CcSEcCtD
Phenylephrine—Abdominal pain upper—Estradiol—osteoporosis	0.00197	0.00315	CcSEcCtD
Phenylephrine—Cardiac disorder—Pamidronate—osteoporosis	0.00197	0.00315	CcSEcCtD
Phenylephrine—Nervous system disorder—Estropipate—osteoporosis	0.00197	0.00315	CcSEcCtD
Phenylephrine—Chest pain—Calcitriol—osteoporosis	0.00196	0.00314	CcSEcCtD
Phenylephrine—Mental disorder—Risedronate—osteoporosis	0.00195	0.00313	CcSEcCtD
Phenylephrine—Skin disorder—Estropipate—osteoporosis	0.00195	0.00312	CcSEcCtD
Phenylephrine—Angiopathy—Pamidronate—osteoporosis	0.00192	0.00308	CcSEcCtD
Phenylephrine—Immune system disorder—Pamidronate—osteoporosis	0.00192	0.00307	CcSEcCtD
Phenylephrine—Mediastinal disorder—Pamidronate—osteoporosis	0.00191	0.00306	CcSEcCtD
Phenylephrine—Shock—Raloxifene—osteoporosis	0.00191	0.00306	CcSEcCtD
Phenylephrine—Nervous system disorder—Raloxifene—osteoporosis	0.00191	0.00305	CcSEcCtD
Phenylephrine—Shock—Ibandronate—osteoporosis	0.00189	0.00303	CcSEcCtD
Phenylephrine—Skin disorder—Raloxifene—osteoporosis	0.00189	0.00302	CcSEcCtD
Phenylephrine—Nervous system disorder—Ibandronate—osteoporosis	0.00189	0.00302	CcSEcCtD
Phenylephrine—Hyperhidrosis—Raloxifene—osteoporosis	0.00188	0.00301	CcSEcCtD
Phenylephrine—Skin disorder—Ibandronate—osteoporosis	0.00187	0.00299	CcSEcCtD
Phenylephrine—Hyperhidrosis—Ibandronate—osteoporosis	0.00186	0.00298	CcSEcCtD
Phenylephrine—Nausea—Ergocalciferol—osteoporosis	0.00185	0.00297	CcSEcCtD
Phenylephrine—Urticaria—Etidronic acid—osteoporosis	0.00184	0.00295	CcSEcCtD
Phenylephrine—Skin disorder—Calcitriol—osteoporosis	0.00183	0.00293	CcSEcCtD
Phenylephrine—Sweating increased—Estradiol—osteoporosis	0.00182	0.00291	CcSEcCtD
Phenylephrine—Tension—Pamidronate—osteoporosis	0.00181	0.0029	CcSEcCtD
Phenylephrine—Dysgeusia—Pamidronate—osteoporosis	0.00181	0.00289	CcSEcCtD
Phenylephrine—Paraesthesia—Estropipate—osteoporosis	0.0018	0.00288	CcSEcCtD
Phenylephrine—Cardiac disorder—Zoledronate—osteoporosis	0.0018	0.00288	CcSEcCtD
Phenylephrine—Visual impairment—Conjugated Estrogens—osteoporosis	0.0018	0.00288	CcSEcCtD
Phenylephrine—Nervousness—Pamidronate—osteoporosis	0.00179	0.00287	CcSEcCtD
Phenylephrine—Angiopathy—Zoledronate—osteoporosis	0.00176	0.00281	CcSEcCtD
Phenylephrine—Immune system disorder—Zoledronate—osteoporosis	0.00175	0.0028	CcSEcCtD
Phenylephrine—Mediastinal disorder—Zoledronate—osteoporosis	0.00175	0.00279	CcSEcCtD
Phenylephrine—Syncope—Risedronate—osteoporosis	0.00174	0.00279	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Estropipate—osteoporosis	0.00173	0.00277	CcSEcCtD
Phenylephrine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00173	0.00277	CcSEcCtD
Phenylephrine—Arrhythmia—Zoledronate—osteoporosis	0.00173	0.00277	CcSEcCtD
Phenylephrine—Paraesthesia—Ibandronate—osteoporosis	0.00173	0.00276	CcSEcCtD
Phenylephrine—Pain—Estropipate—osteoporosis	0.00172	0.00275	CcSEcCtD
Phenylephrine—Hypersensitivity—Etidronic acid—osteoporosis	0.00171	0.00273	CcSEcCtD
Phenylephrine—Loss of consciousness—Risedronate—osteoporosis	0.00171	0.00273	CcSEcCtD
Phenylephrine—Mental disorder—Zoledronate—osteoporosis	0.0017	0.00272	CcSEcCtD
Phenylephrine—Agitation—Pamidronate—osteoporosis	0.0017	0.00272	CcSEcCtD
Phenylephrine—Angiopathy—Conjugated Estrogens—osteoporosis	0.00169	0.00271	CcSEcCtD
Phenylephrine—Pain—Alendronate—osteoporosis	0.00169	0.0027	CcSEcCtD
Phenylephrine—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00168	0.0027	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00168	0.0027	CcSEcCtD
Phenylephrine—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00168	0.00269	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00168	0.00268	CcSEcCtD
Phenylephrine—Hypertension—Risedronate—osteoporosis	0.00168	0.00268	CcSEcCtD
Phenylephrine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00167	0.00267	CcSEcCtD
Phenylephrine—Pain—Raloxifene—osteoporosis	0.00166	0.00266	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00166	0.00266	CcSEcCtD
Phenylephrine—Syncope—Pamidronate—osteoporosis	0.00166	0.00265	CcSEcCtD
Phenylephrine—Chest pain—Risedronate—osteoporosis	0.00165	0.00265	CcSEcCtD
Phenylephrine—Dysgeusia—Zoledronate—osteoporosis	0.00165	0.00264	CcSEcCtD
Phenylephrine—Pain—Ibandronate—osteoporosis	0.00164	0.00263	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00164	0.00263	CcSEcCtD
Phenylephrine—Pruritus—Etidronic acid—osteoporosis	0.00164	0.00263	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Estradiol—osteoporosis	0.00164	0.00262	CcSEcCtD
Phenylephrine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00163	0.00262	CcSEcCtD
Phenylephrine—Myocardial infarction—Estradiol—osteoporosis	0.00163	0.00261	CcSEcCtD
Phenylephrine—Loss of consciousness—Pamidronate—osteoporosis	0.00162	0.0026	CcSEcCtD
Phenylephrine—Pain—Calcitriol—osteoporosis	0.00161	0.00258	CcSEcCtD
Phenylephrine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00159	0.00255	CcSEcCtD
Phenylephrine—Hypertension—Pamidronate—osteoporosis	0.00159	0.00255	CcSEcCtD
Phenylephrine—Tension—Conjugated Estrogens—osteoporosis	0.00159	0.00255	CcSEcCtD
Phenylephrine—Urticaria—Estropipate—osteoporosis	0.00159	0.00255	CcSEcCtD
Phenylephrine—Dysgeusia—Conjugated Estrogens—osteoporosis	0.00159	0.00255	CcSEcCtD
Phenylephrine—Vision blurred—Zoledronate—osteoporosis	0.00159	0.00254	CcSEcCtD
Phenylephrine—Tremor—Zoledronate—osteoporosis	0.00158	0.00253	CcSEcCtD
Phenylephrine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00158	0.00253	CcSEcCtD
Phenylephrine—Nervousness—Conjugated Estrogens—osteoporosis	0.00158	0.00252	CcSEcCtD
Phenylephrine—Urticaria—Alendronate—osteoporosis	0.00157	0.00251	CcSEcCtD
Phenylephrine—Shock—Risedronate—osteoporosis	0.00156	0.0025	CcSEcCtD
Phenylephrine—Nervous system disorder—Risedronate—osteoporosis	0.00155	0.00249	CcSEcCtD
Phenylephrine—Agitation—Zoledronate—osteoporosis	0.00155	0.00248	CcSEcCtD
Phenylephrine—Skin disorder—Risedronate—osteoporosis	0.00154	0.00246	CcSEcCtD
Phenylephrine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00153	0.00245	CcSEcCtD
Phenylephrine—Urticaria—Ibandronate—osteoporosis	0.00153	0.00245	CcSEcCtD
Phenylephrine—Syncope—Zoledronate—osteoporosis	0.00151	0.00242	CcSEcCtD
Phenylephrine—Urticaria—Calcitriol—osteoporosis	0.0015	0.00239	CcSEcCtD
Phenylephrine—Palpitations—Zoledronate—osteoporosis	0.00149	0.00239	CcSEcCtD
Phenylephrine—Shock—Pamidronate—osteoporosis	0.00148	0.00237	CcSEcCtD
Phenylephrine—Loss of consciousness—Zoledronate—osteoporosis	0.00148	0.00237	CcSEcCtD
Phenylephrine—Hypersensitivity—Estropipate—osteoporosis	0.00148	0.00237	CcSEcCtD
Phenylephrine—Nervous system disorder—Pamidronate—osteoporosis	0.00148	0.00237	CcSEcCtD
Phenylephrine—Vomiting—Etidronic acid—osteoporosis	0.00147	0.00236	CcSEcCtD
Phenylephrine—Tachycardia—Pamidronate—osteoporosis	0.00147	0.00235	CcSEcCtD
Phenylephrine—Rash—Etidronic acid—osteoporosis	0.00146	0.00234	CcSEcCtD
Phenylephrine—Dermatitis—Etidronic acid—osteoporosis	0.00146	0.00234	CcSEcCtD
Phenylephrine—Hyperhidrosis—Pamidronate—osteoporosis	0.00146	0.00233	CcSEcCtD
Phenylephrine—Syncope—Conjugated Estrogens—osteoporosis	0.00146	0.00233	CcSEcCtD
Phenylephrine—Hypertension—Zoledronate—osteoporosis	0.00146	0.00233	CcSEcCtD
Phenylephrine—Hypersensitivity—Alendronate—osteoporosis	0.00146	0.00233	CcSEcCtD
Phenylephrine—Headache—Etidronic acid—osteoporosis	0.00145	0.00232	CcSEcCtD
Phenylephrine—Visual impairment—Estradiol—osteoporosis	0.00144	0.0023	CcSEcCtD
Phenylephrine—Chest pain—Zoledronate—osteoporosis	0.00144	0.0023	CcSEcCtD
Phenylephrine—Palpitations—Conjugated Estrogens—osteoporosis	0.00143	0.0023	CcSEcCtD
Phenylephrine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00143	0.00228	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00143	0.00228	CcSEcCtD
Phenylephrine—Paraesthesia—Risedronate—osteoporosis	0.00142	0.00228	CcSEcCtD
Phenylephrine—Pruritus—Estropipate—osteoporosis	0.00142	0.00227	CcSEcCtD
Phenylephrine—Hypersensitivity—Ibandronate—osteoporosis	0.00142	0.00227	CcSEcCtD
Phenylephrine—Dyspnoea—Risedronate—osteoporosis	0.00141	0.00226	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.0014	0.00225	CcSEcCtD
Phenylephrine—Pruritus—Alendronate—osteoporosis	0.0014	0.00224	CcSEcCtD
Phenylephrine—Hypersensitivity—Calcitriol—osteoporosis	0.00139	0.00222	CcSEcCtD
Phenylephrine—Cardiac disorder—Estradiol—osteoporosis	0.00139	0.00222	CcSEcCtD
Phenylephrine—Chest pain—Conjugated Estrogens—osteoporosis	0.00138	0.00221	CcSEcCtD
Phenylephrine—Nausea—Etidronic acid—osteoporosis	0.00138	0.0022	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00137	0.0022	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Risedronate—osteoporosis	0.00137	0.00219	CcSEcCtD
Phenylephrine—Pruritus—Ibandronate—osteoporosis	0.00136	0.00218	CcSEcCtD
Phenylephrine—Pain—Risedronate—osteoporosis	0.00136	0.00217	CcSEcCtD
Phenylephrine—Angiopathy—Estradiol—osteoporosis	0.00135	0.00217	CcSEcCtD
Phenylephrine—Shock—Zoledronate—osteoporosis	0.00135	0.00217	CcSEcCtD
Phenylephrine—Paraesthesia—Pamidronate—osteoporosis	0.00135	0.00217	CcSEcCtD
Phenylephrine—Nervous system disorder—Zoledronate—osteoporosis	0.00135	0.00216	CcSEcCtD
Phenylephrine—Immune system disorder—Estradiol—osteoporosis	0.00135	0.00216	CcSEcCtD
Phenylephrine—Mediastinal disorder—Estradiol—osteoporosis	0.00135	0.00215	CcSEcCtD
Phenylephrine—Dyspnoea—Pamidronate—osteoporosis	0.00134	0.00215	CcSEcCtD
Phenylephrine—Tachycardia—Zoledronate—osteoporosis	0.00134	0.00215	CcSEcCtD
Phenylephrine—Skin disorder—Zoledronate—osteoporosis	0.00134	0.00214	CcSEcCtD
Phenylephrine—Pruritus—Calcitriol—osteoporosis	0.00133	0.00213	CcSEcCtD
Phenylephrine—Hyperhidrosis—Zoledronate—osteoporosis	0.00133	0.00213	CcSEcCtD
Phenylephrine—Dizziness—Estropipate—osteoporosis	0.00133	0.00212	CcSEcCtD
Phenylephrine—Mental disorder—Estradiol—osteoporosis	0.00131	0.00209	CcSEcCtD
Phenylephrine—Dizziness—Alendronate—osteoporosis	0.00131	0.00209	CcSEcCtD
Phenylephrine—Shock—Conjugated Estrogens—osteoporosis	0.0013	0.00209	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.0013	0.00208	CcSEcCtD
Phenylephrine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.0013	0.00208	CcSEcCtD
Phenylephrine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00129	0.00207	CcSEcCtD
Phenylephrine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00129	0.00207	CcSEcCtD
Phenylephrine—Pain—Pamidronate—osteoporosis	0.00129	0.00206	CcSEcCtD
Phenylephrine—Skin disorder—Conjugated Estrogens—osteoporosis	0.00129	0.00206	CcSEcCtD
Phenylephrine—Dizziness—Raloxifene—osteoporosis	0.00128	0.00206	CcSEcCtD
Phenylephrine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00128	0.00205	CcSEcCtD
Phenylephrine—Tension—Estradiol—osteoporosis	0.00128	0.00204	CcSEcCtD
Phenylephrine—Vomiting—Estropipate—osteoporosis	0.00128	0.00204	CcSEcCtD
Phenylephrine—Dysgeusia—Estradiol—osteoporosis	0.00127	0.00204	CcSEcCtD
Phenylephrine—Dizziness—Ibandronate—osteoporosis	0.00127	0.00204	CcSEcCtD
Phenylephrine—Rash—Estropipate—osteoporosis	0.00126	0.00202	CcSEcCtD
Phenylephrine—Dermatitis—Estropipate—osteoporosis	0.00126	0.00202	CcSEcCtD
Phenylephrine—Nervousness—Estradiol—osteoporosis	0.00126	0.00202	CcSEcCtD
Phenylephrine—Urticaria—Risedronate—osteoporosis	0.00126	0.00202	CcSEcCtD
Phenylephrine—Headache—Estropipate—osteoporosis	0.00126	0.00201	CcSEcCtD
Phenylephrine—Vomiting—Alendronate—osteoporosis	0.00126	0.00201	CcSEcCtD
Phenylephrine—Rash—Alendronate—osteoporosis	0.00125	0.00199	CcSEcCtD
Phenylephrine—Dermatitis—Alendronate—osteoporosis	0.00124	0.00199	CcSEcCtD
Phenylephrine—Headache—Alendronate—osteoporosis	0.00124	0.00198	CcSEcCtD
Phenylephrine—Paraesthesia—Zoledronate—osteoporosis	0.00124	0.00198	CcSEcCtD
Phenylephrine—Vomiting—Raloxifene—osteoporosis	0.00124	0.00198	CcSEcCtD
Phenylephrine—Dyspnoea—Zoledronate—osteoporosis	0.00123	0.00196	CcSEcCtD
Phenylephrine—Rash—Raloxifene—osteoporosis	0.00122	0.00196	CcSEcCtD
Phenylephrine—Dermatitis—Raloxifene—osteoporosis	0.00122	0.00196	CcSEcCtD
Phenylephrine—Vomiting—Ibandronate—osteoporosis	0.00122	0.00196	CcSEcCtD
Phenylephrine—Tremor—Estradiol—osteoporosis	0.00122	0.00195	CcSEcCtD
Phenylephrine—Headache—Raloxifene—osteoporosis	0.00122	0.00195	CcSEcCtD
Phenylephrine—Rash—Ibandronate—osteoporosis	0.00121	0.00194	CcSEcCtD
Phenylephrine—Dermatitis—Ibandronate—osteoporosis	0.00121	0.00194	CcSEcCtD
Phenylephrine—Headache—Ibandronate—osteoporosis	0.0012	0.00193	CcSEcCtD
Phenylephrine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.0012	0.00192	CcSEcCtD
Phenylephrine—Vomiting—Calcitriol—osteoporosis	0.0012	0.00192	CcSEcCtD
Phenylephrine—Agitation—Estradiol—osteoporosis	0.00119	0.00191	CcSEcCtD
Phenylephrine—Nausea—Estropipate—osteoporosis	0.00119	0.00191	CcSEcCtD
Phenylephrine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00119	0.0019	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00119	0.0019	CcSEcCtD
Phenylephrine—Rash—Calcitriol—osteoporosis	0.00119	0.0019	CcSEcCtD
Phenylephrine—Dermatitis—Calcitriol—osteoporosis	0.00119	0.0019	CcSEcCtD
Phenylephrine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00118	0.00189	CcSEcCtD
Phenylephrine—Headache—Calcitriol—osteoporosis	0.00118	0.00189	CcSEcCtD
Phenylephrine—Pain—Zoledronate—osteoporosis	0.00118	0.00188	CcSEcCtD
Phenylephrine—Nausea—Alendronate—osteoporosis	0.00117	0.00188	CcSEcCtD
Phenylephrine—Hypersensitivity—Risedronate—osteoporosis	0.00117	0.00187	CcSEcCtD
Phenylephrine—Syncope—Estradiol—osteoporosis	0.00117	0.00187	CcSEcCtD
Phenylephrine—Nausea—Raloxifene—osteoporosis	0.00115	0.00185	CcSEcCtD
Phenylephrine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00115	0.00184	CcSEcCtD
Phenylephrine—Palpitations—Estradiol—osteoporosis	0.00115	0.00184	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00114	0.00183	CcSEcCtD
Phenylephrine—Nausea—Ibandronate—osteoporosis	0.00114	0.00183	CcSEcCtD
Phenylephrine—Loss of consciousness—Estradiol—osteoporosis	0.00114	0.00183	CcSEcCtD
Phenylephrine—Pain—Conjugated Estrogens—osteoporosis	0.00113	0.00181	CcSEcCtD
Phenylephrine—Hypertension—Estradiol—osteoporosis	0.00112	0.0018	CcSEcCtD
Phenylephrine—Pruritus—Risedronate—osteoporosis	0.00112	0.0018	CcSEcCtD
Phenylephrine—Nausea—Calcitriol—osteoporosis	0.00112	0.00179	CcSEcCtD
Phenylephrine—Hypersensitivity—Pamidronate—osteoporosis	0.00111	0.00178	CcSEcCtD
Phenylephrine—Chest pain—Estradiol—osteoporosis	0.00111	0.00177	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.0011	0.00176	CcSEcCtD
Phenylephrine—Urticaria—Zoledronate—osteoporosis	0.00109	0.00175	CcSEcCtD
Phenylephrine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00107	0.00172	CcSEcCtD
Phenylephrine—Pruritus—Pamidronate—osteoporosis	0.00107	0.00171	CcSEcCtD
Phenylephrine—Urticaria—Conjugated Estrogens—osteoporosis	0.00105	0.00169	CcSEcCtD
Phenylephrine—Dizziness—Risedronate—osteoporosis	0.00105	0.00168	CcSEcCtD
Phenylephrine—Shock—Estradiol—osteoporosis	0.00104	0.00167	CcSEcCtD
Phenylephrine—Nervous system disorder—Estradiol—osteoporosis	0.00104	0.00166	CcSEcCtD
Phenylephrine—Tachycardia—Estradiol—osteoporosis	0.00104	0.00166	CcSEcCtD
Phenylephrine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00103	0.00165	CcSEcCtD
Phenylephrine—Skin disorder—Estradiol—osteoporosis	0.00103	0.00165	CcSEcCtD
Phenylephrine—Hyperhidrosis—Estradiol—osteoporosis	0.00103	0.00164	CcSEcCtD
Phenylephrine—Rash—Ethinyl Estradiol—osteoporosis	0.00102	0.00164	CcSEcCtD
Phenylephrine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00102	0.00164	CcSEcCtD
Phenylephrine—Headache—Ethinyl Estradiol—osteoporosis	0.00102	0.00163	CcSEcCtD
Phenylephrine—Hypersensitivity—Zoledronate—osteoporosis	0.00101	0.00162	CcSEcCtD
Phenylephrine—Vomiting—Risedronate—osteoporosis	0.00101	0.00161	CcSEcCtD
Phenylephrine—Rash—Risedronate—osteoporosis	0.000999	0.0016	CcSEcCtD
Phenylephrine—Dermatitis—Risedronate—osteoporosis	0.000998	0.0016	CcSEcCtD
Phenylephrine—Dizziness—Pamidronate—osteoporosis	0.000996	0.00159	CcSEcCtD
Phenylephrine—Headache—Risedronate—osteoporosis	0.000993	0.00159	CcSEcCtD
Phenylephrine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000976	0.00156	CcSEcCtD
Phenylephrine—Pruritus—Zoledronate—osteoporosis	0.000974	0.00156	CcSEcCtD
Phenylephrine—Nausea—Ethinyl Estradiol—osteoporosis	0.000966	0.00155	CcSEcCtD
Phenylephrine—Vomiting—Pamidronate—osteoporosis	0.000958	0.00153	CcSEcCtD
Phenylephrine—Paraesthesia—Estradiol—osteoporosis	0.000952	0.00152	CcSEcCtD
Phenylephrine—Rash—Pamidronate—osteoporosis	0.00095	0.00152	CcSEcCtD
Phenylephrine—Dermatitis—Pamidronate—osteoporosis	0.000949	0.00152	CcSEcCtD
Phenylephrine—Dyspnoea—Estradiol—osteoporosis	0.000946	0.00151	CcSEcCtD
Phenylephrine—Headache—Pamidronate—osteoporosis	0.000944	0.00151	CcSEcCtD
Phenylephrine—Nausea—Risedronate—osteoporosis	0.000941	0.00151	CcSEcCtD
Phenylephrine—Pruritus—Conjugated Estrogens—osteoporosis	0.000938	0.0015	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000916	0.00147	CcSEcCtD
Phenylephrine—Dizziness—Zoledronate—osteoporosis	0.00091	0.00146	CcSEcCtD
Phenylephrine—Pain—Estradiol—osteoporosis	0.000907	0.00145	CcSEcCtD
Phenylephrine—Nausea—Pamidronate—osteoporosis	0.000895	0.00143	CcSEcCtD
Phenylephrine—Dizziness—Conjugated Estrogens—osteoporosis	0.000876	0.0014	CcSEcCtD
Phenylephrine—Vomiting—Zoledronate—osteoporosis	0.000875	0.0014	CcSEcCtD
Phenylephrine—Rash—Zoledronate—osteoporosis	0.000868	0.00139	CcSEcCtD
Phenylephrine—Dermatitis—Zoledronate—osteoporosis	0.000867	0.00139	CcSEcCtD
Phenylephrine—Headache—Zoledronate—osteoporosis	0.000862	0.00138	CcSEcCtD
Phenylephrine—Vomiting—Conjugated Estrogens—osteoporosis	0.000843	0.00135	CcSEcCtD
Phenylephrine—Urticaria—Estradiol—osteoporosis	0.000843	0.00135	CcSEcCtD
Phenylephrine—Rash—Conjugated Estrogens—osteoporosis	0.000836	0.00134	CcSEcCtD
Phenylephrine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000835	0.00134	CcSEcCtD
Phenylephrine—Headache—Conjugated Estrogens—osteoporosis	0.00083	0.00133	CcSEcCtD
Phenylephrine—Nausea—Zoledronate—osteoporosis	0.000817	0.00131	CcSEcCtD
Phenylephrine—Nausea—Conjugated Estrogens—osteoporosis	0.000787	0.00126	CcSEcCtD
Phenylephrine—Hypersensitivity—Estradiol—osteoporosis	0.000781	0.00125	CcSEcCtD
Phenylephrine—Pruritus—Estradiol—osteoporosis	0.00075	0.0012	CcSEcCtD
Phenylephrine—Dizziness—Estradiol—osteoporosis	0.000701	0.00112	CcSEcCtD
Phenylephrine—Vomiting—Estradiol—osteoporosis	0.000674	0.00108	CcSEcCtD
Phenylephrine—Rash—Estradiol—osteoporosis	0.000669	0.00107	CcSEcCtD
Phenylephrine—Dermatitis—Estradiol—osteoporosis	0.000668	0.00107	CcSEcCtD
Phenylephrine—Headache—Estradiol—osteoporosis	0.000664	0.00106	CcSEcCtD
Phenylephrine—Nausea—Estradiol—osteoporosis	0.00063	0.00101	CcSEcCtD
